Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 9 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, April 22, 2026 –…
NETRIS Pharma: Nature publishes positive pancreatic cancer Phase 1b data for NP137 anti-netrin-1 monoclonal antibody
LAPNET-01 Phase 1b study shows netrin-1 blockade may overcome and prevent chemoresistance in patients with pancreatic ductal adenocarcinoma (PDAC) with locally advanced PDAC (LAPC) NP137 is the first-in-class anti-netrin-1 monoclonal antibody (mAb)…
Should You Forget Pfizer and Buy This Pharma Stock Instead?
Pfizer (PFE 1.68%) and AbbVie (ABBV 1.20%) are two pharmaceutical giants that seem to be headed in opposite directions. Pfizer's stock is up by more than 10% this year, while AbbVie's shares have fallen more than 7%. But when you look at their…
Pharma giant AbbVie plans $1.4 billion campus near Research Triangle Park
AbbVie, a biopharmaceutical giant, will invest $1.4 billion into a new facility in Durham, the company and the N.C. Department of Commerce announced Wednesday. Why it matters: The expansion is yet another win from the pharmaceutical industry for…
Natco Pharma: A high-margin business or a volatility trap at 10x earnings?
What drives the margins, and can they hold? What is the semaglutide opportunity worth in unit-economic terms? Does the 10x multiple reflect a structural discount or a mispriced opportunity? A business built on windows, not volume Unlike traditional…
Amazon Targets the GLP-1 Gap Big Pharma Left Open
Amazon built one system to handle all of it. Through its One Medical arm, the company launched a GLP-1 Management Program bundling clinical screening, prescriptions, ongoing supervision and pharmacy delivery into a single offering. The program…
3 Air Quality Myths Costing Your Lab Money And Safety
Air quality in life science labs isn't the kind of topic that grabs headlines. It can't compete with breakthrough Alzheimer's treatments or the next‑generation immunotherapies transforming oncology and yet, it's what they hinge on. Behind…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - What's Next?
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) gapped down prior to trading on Wednesday. The stock had previously closed at $51.33, but opened at $48.14. Zealand Pharma A/S shares last traded at $48.14, with a volume of 118 shares changing…
Ruffer LLP Has $3.50 Million Stake in Royalty Pharma PLC $RPRX
Ruffer LLP decreased its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 30.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional…
Using AI To Personalize Healthcare-Without Losing Patient Trust
In this week's edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more. To get it in your…
Stock Market Today: How Will Sensex, Nifty 50 Trade On April 22?
Stock Market Today: The Indian stock market is expected to open lower on Wednesday, following mixed global market cues, amid cautiousness over the US-Iran ceasefire and as the blockade of the Strait of Hormuz continues. The trends on Gift Nifty…
Stock Market Opening Bell: Sensex Falls 0.32%, Nifty 50 Plummets 0.43%
Amid global uncertainty over the US-Iran ceasefire and continued blockade of the Strait of Hormuz, the Indian stock market benchmark indices opened in red on Wednesday, April 22. While the Sensex declined 0.32% to 79,019.34 level, Nifty 50…
Inhibrx: Spinoff Rumors Send Shares Soaring - Stunning Bull Run Can Continue (NASDAQ:INBX)
Inhibrx Biosciences, Inc. has surged nearly 40% amid rumors of Big Pharma interest in joint spinoffs of INBRX-106 and possibly a second asset. Ozekibart's Phase 2 data in chondrosarcoma showed a 52% risk reduction in progression or death…
Elkedonia strengthens Board of Directors with appointment of Pierre d'Epenoux as Independent Chairman
Appointment strengthens Elkedonia's governance as the company continues its development and prepares for its next phases of growth Pierre d'Epenoux is former CEO of ImCheck Therapeutics, a clinical-stage biotech immuno-oncology company acquired by…
Cardinal Health (CAH) Q1 2025 Earnings Transcript
Friday, November 1, 2024 at 8:30 a.m. ET Chief Executive Officer — Jason Hollar Chief Financial Officer — Aaron Alt Revenue -- $52 billion, down 4%, reflecting the large customer transition; revenue rose 15% excluding this impact.
Receive a Daily briefing on Pharma Industry News
Get Started